products
 
작성일 : 22-04-21
[Iris Biotech] Valine-Alanine-Based Enzymatically Cleavable Linkers

 

Valine-Alanine-Based Enzymatically Cleavable Linkers

 

Peptidic bonds are expected to have a high serum stability, as lysosomal proteolytic enzymes show

reduced activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood

compared to lysosomes. This was confirmed by preclinical in vivo studies which revealed half-lives of

seven to ten days for peptide linkers. Release of a drug conjugated via a peptidyl linker to monoclonal

antibodies (mAb) occurs specifically due to the action of lysosomal proteases (e.g., cathepsin and plasmin)

. These proteases may be present at even elevated levels in certain tumor tissues. Therefore, peptide linkers

combine greater systemic stability with rapid enzymatic release of the drug in the target cell. Besides Val-

Ala, Val-Cit and Phe-Lys, other sequences have been reported as lysosomally cleavable peptides, like Gly-

Phe-Leu-Gly and Ala-Leu-Ala-Leu.

 

 클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

Figure 1: Cyclobutane-1,1-dicarboxamide can replace valine in dipeptide linker systems, resulting in

improved ADC selectivity.

 

Peptide-based ADC linkers, like Val-Cit or Val-Ala, that are cleaved by lysosomal proteases have shown

sufficient stability in serum and effective payload-release in targeted cells. However, the use of peptide-

based linkers limits the ability to modulate protease specificity. Furthermore, if the linker can preferentially be

hydrolyzed by tumor-specific proteases only, safety margin may improve. In this context, a cyclobutane-

1,1-dicarboxamide-containing linker replacing valine in other sequences has been invented which is

hydrolyzed predominantly by cathepsin B, while the typical valine-citrulline dipeptide linker is rather less.

ADCs bearing the nonpeptidic linker are as efficacious and stable in vivo as those with the dipeptide linker.

Hence, the application of the peptidomimetic linker presents new opportunities for improving the selectivity of

ADCs.

 

6-Azidohexanoyl-Val-Ala-PAB

Chemical name:

 

6-azidohexanoyl-valyl-alanyl-(4-aminobenzyl alcohol)

Cas-no.:

 

N/A

Formula:

 

C21H32N6O4

Molecular weight:

 

432.52 g/mol

 

 

 클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

 

6-Azidohexanoyl-Val-Ala-PAB-PNP

Chemical name:

 

6-azidohexanoyl-valyl-alanyl-(4-aminobenzyl)-(4-nitrophenyl)-carbonate

Cas-no.:

 

N/A

Formula:

 

C28H35N7O8

Molecular weight:

 

597.62 g/mol

 

 

 클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

 

Azido-PEG(4)-Val-Ala-PAB

Chemical name:

 

azido-tetraethyleneglycol-propanoyl-valyl-alanyl-(4-aminobenzylalcohol)

Cas-no.:

 

N/A

Formula:

 

C26H42N6O8

Molecular weight:

 

566.65 g/mol

 

 

 클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

 

Azido-PEG(4)-Val-Ala-PAB-PNP

Chemical name:

 

azido-tetraethyleneglycol-propanoyl-valyl-alanyl-(4-aminobenzyl)-(4-nitrophenyl)

 

 

-carbonate

Cas-no.:

 

N/A

Formula:

 

C33H45N7O12

Molecular weight:

 

731.75 g/mol

 

 

 클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

 

4-Pentynoyl-Val-Ala-PAB

Chemical name:

 

4-pentynoyl-valyl-alanyl-(4-aminobenzyl alcohol)

Cas-no.:

 

1956294-75-9

Formula:

 

C20H27N3O4

Molecular weight:

 

373.45 g/mol

 

 

 클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

   

Ordering informations

    

Catalog No.

Product Name

Size

ADC1290

6-Azidohexanoyl-Val-Ala-PAB

100 mg & 250 mg

ADC1300

6-Azidohexanoyl-Val-Ala-PAB-PNP

100 mg & 250 mg

ADC1330

Azido-PEG(4)-Val-Ala-PAB

100 mg & 250 mg

ADC1340

Azido-PEG(4)-Val-Ala-PAB-PNP

100 mg & 250 mg

ADC1310

4-Pentynoyl-Val-Ala-PAB

100 mg & 250 mg

 

 

▣ 관련 페이지 ; Iris Biotech GMBH